Point-of-care platforms, genetic assays and wireless connectivity
Nucleic acids, which are among the best signatures of disease and pathogens, have traditionally been measured in centralised screening facilities using expensive instruments. Such tests are seldom available on point-of-care (POC) testing platforms. Advancements in simple microfluidics, cellphones and low-cost devices, isothermal and other novel amplification techniques, and reagent stabilisation approaches are now making it […]
